MedPath
NMPA Approval

Sodium Hyaluronate Eye Drops

国药准字H20247326

December 20, 2024

国药准字H20233883

Drug Information

玻璃酸钠滴眼液

眼用制剂

0.3%(0.4ml:1.2mg)

化学药品

December 20, 2024

Company Information

Applicant Company

湖北省武汉市经济技术开发区高新技术工业园28号

Manufacturing Company

湖北省武汉市经济技术开发区高新技术工业园28号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

玻璃酸钠滴眼液 - NMPA 批准文号 | MedPath